Central Pacific Bank - Trust Division’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217K | Buy |
1,725
+100
| +6% | +$12.6K | 0.03% | 426 |
|
|
2025
Q1 | $180K | Sell |
1,625
-2,077
| -56% | -$230K | 0.02% | 463 |
|
|
2024
Q4 | $505K | Sell |
3,702
-1,200
| -24% | -$164K | 0.07% | 262 |
|
|
2024
Q3 | $565K | Sell |
4,902
-2,335
| -32% | -$269K | 0.07% | 261 |
|
|
2024
Q2 | $996K | Buy |
7,237
+937
| +15% | +$129K | 0.12% | 181 |
|
|
2024
Q1 | $891K | Buy |
+6,300
| New | +$891K | 0.11% | 208 |
|